Vanarix is a swiss clinical-stage company that focuses on articular cartilage regeneration.
Vanarix has raised $4.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Vanarix is headquartered in Lausanne, Switzerland.
Vanarix is a swiss clinical-stage company that focuses on articular cartilage regeneration.
Vanarix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vanarix — Funding & Investors." VCBacked, July 10, 2024, https://www.vcbacked.co/company/vanarix. Accessed August 13, 2026.
VCBacked. (2024). Vanarix — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/vanarix
{{cite web |title=Vanarix — Funding & Investors |url=https://www.vcbacked.co/company/vanarix |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated